Citation: G. Steffensen et al., EVIDENCE THAT TREATMENT OF ESRD PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN INDUCES IMMUNOSUPPRESSION WITHOUT AFFECTING THE DISTRIBUTIONOF PERIPHERAL-BLOOD MONONUCLEAR CELL SUBPOPULATIONS, Clinical nephrology, 45(2), 1996, pp. 98-103
Citation: G. Steffensen et Na. Aunsholt, IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON PLASMINOGEN-ACTIVATOR INHIBITOR, AND PROTEIN-C AND PROTEIN-S ACTIVITY, American journal of nephrology, 16(5), 1996, pp. 453-454
Citation: G. Steffensen et Na. Aunsholt, DOES ERYTHROPOIETIN CAUSE HORMONAL CHANGES IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 8(11), 1993, pp. 1215-1218
Citation: G. Steffensen et al., COMPARATIVE CROSSOVER STUDY OF INTRAVENOUSLY AND SUBCUTANEOUSLY ADMINISTERED RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS, Blood purification, 10(5-6), 1992, pp. 241-247
Citation: Na. Aunsholt et al., INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLATELET-FUNCTION AND COAGULATION-FACTORS, Blood purification, 10(5-6), 1992, pp. 248-253
Citation: Na. Aunsholt et C. Larsen, THE ARTERIAL OXYGEN EXTRACTION TENSION AND OXYGEN COMPENSATION FACTORDURING ACETATE AND BICARBONATE DIALYSIS, Blood purification, 10(5-6), 1992, pp. 317-325